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The current study sought to investigate the capacities of single and combinatorial herbal formulations of
leaf extracts of Acanthus montanus, Asystasia gangetica, Emilia coccinea, and Hibiscus rosasinensis to
reverse hyperglycemia and dyslipidemia in alloxan-induced diabetic male rats. Phytochemical compo-
sition of the herbal extracts, fasting plasma glucose concentration (FPGC), and serum lipid proﬁle (SLP) of
the rats were measured by standard methods. The relative abundance of phytochemicals in the four
experimental leaf extracts was in the following order: ﬂavonoids > alkaloids > saponins > tannins.
Hyperglycemic rats (HyGR) treated with single and combinatorial herbal formulations showed evidence
of reduced FPGC compared with the untreated HyGR and were normoglycemic (FPGC < 110.0 mg/dL).
Similarly, HyGR treated with single and combinatorial herbal formulations showed evidence of read-
justments in their SLPs. Generally, HyGR treated with triple herbal formulations (THfs) exhibited the
highest atherogenic index compared with HyGR treated with single herbal formulations (SHfs), double
herbal formulations (DHfs), and quadruple herbal formulation (QHf). The display of synergy or antago-
nism by the composite herbal extracts in ameliorating hyperglycemia and dyslipidemia depended on the
type and number of individual herbal extract used in constituting the experimental herbal formulations.
Furthermore, the capacities of the herbal formulations (SHfs, DHfs, THfs, and QHf) to exert glycemic
control and reverse dyslipidemia did not follow predictable patterns in the animal models.
Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Hyperglycemia and dyslipidemia, among other disorders, are
metabolic syndromes associated with a dysfunctional endocrine
system clinically referred to as diabetes mellitus (DM).1e3 DM is
described and classiﬁed on the basis of intrinsic and extrinsic
causative factors, which has been exhaustively explained else-
where.4e7 Although the etiology of DM is multifaceted, the preva-
lence of the disease worldwide is often linked to genetic/
physiologic factors, sedentary lifestyle, and obesity,8e11 of which
poor dietary habits such as high consumption of sugars and satu-
rated fats in addition to low intake of polyunsaturated fatty acidsry, Imo State University, PMB
zie).
for Food and Biomolecules,
molecules, National Taiwan Unive(PUFAs) have been implicated to be major contributory factors to-
ward the progression of the disease.12,13
The earliest and common diagnostic indices of DM are hyper-
glycemia and glucosuria. In that regard, the unusual metabolism of
carbohydrates in DM, and associated profound adjustments of
glycolytic pathways14,15 engender the activation of alternative
polyol metabolic pathways with resultant intracellular accumula-
tion of sorbitol16 and auto-oxidation of glucose.17 These distortional
metabolic events have been implicated in the etiology of diabetic
peripheral neuropathy, retinopathy, and cataracts.9,18 Patterns of
dyslipidemia in DM and connecting primary risk factors have been
described in earlier reports.2,19,20 Atherosclerosis-induced coronary
heart disease (CHD), stroke, and hypertension are major causes of
increasing rate of fatalities among patients with DM.21,22
The dilapidating action of DM qualiﬁes it as a disease of major
public health concern and epidemiological survey showed that it is
the seventh leading cause of death worldwide.23 Additionally,
projections showed that the disease will become the foremostrsity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
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cially in Africa and Asia.5,9,24 In addition to the option of DM
management that involves intramuscular administration of insulin
to individuals with diabetes, there are several synthetic antidiabetic
medicinal preparations of notable capacity to act as agents of gly-
cemic control.25e27 However, from a toxicological standpoint,
alternative herbal formulation remedies are sometimes preferred
to synthetic antidiabetic drugs because of its minimal or no side
effects.28,29 Furthermore, because the uses of traditional plant
medicines are cost-effective mitigation strategies, ethnomedicinal
practices are being increasingly applied worldwide for the allevi-
ation and management of DM.9,18,24,30e33 Decoctions from parts or
whole plants of Acanthus montanus, Asystasia gangetica, Emilia
coccinea, and Hibiscus rosasinensis have been effectively applied for
the treatment and management of numerous pathologic con-
ditions.34e39 Most ethnomedicinal practitioners presume that
administration of combinatorial extracts of different plant species
serves to potentiate the efﬁcacy of herbal concoctions40 and may
exhibit competitive therapeutic potentials when compared with
that of orthodoxmedicines.41 Accordingly, the current study sought
to investigate the capacities of single and combinatorial herbal
formulations of leaf extracts of A. montanus, A. gangetica,
E. coccinea, and H. rosasinensis to reverse hyperglycemia and dys-
lipidemia in alloxan induced diabetic male rats.
2. Materials and methods
2.1. Collection and preparation of herbal samples
Fresh leaves of Acanthus montanus (Nees) T. Anderson (ACMO),
Emilia coccinea G. Don (EMCO), and Hibiscus rosasinensis L. (HIRO)
were collected from uncultivated lands in Umuamacha Ayaba
Umaeze, Osisioma Ngwa Local Government Area (LGA), Abia State,
Nigeria, whereas fresh leaves of Asystasia gangetica L. T. Anderson
(ASGA) were collected from Ubowuala, Emekuku, Owerri North
Local Government Area (LGA), Imo State, Nigeria. The four herbs
were identiﬁed and authenticated by Dr. M. Ibe, School of Agri-
culture and Agricultural Technology (SAAT), Federal University of
Technology, Owerri, Nigeria. All the leaves were collected between
the months of July 2009 and August 2009.
The leaves of individual plants were washed with continuous
ﬂow of distilled water for 15 minutes and allowed to dry at labo-
ratory ambient temperature (24 ± 5 C). A 500 g portion of each of
the herbal samples were weighted using a triple beam balance
(OHAU 750-50: Burlington, NC, USA) and dried in an oven (WTC
BINDER, 7200 Tuttlingen, Germany) at 60 C until a constant weight
was achieved. The dried leaves were packaged in dark polyethylene
bags and kept in cold room (7 ± 3 C) for 24 hours prior to pul-
verization. Next, the separate dried leaves were pulverized using a
Thomas-Willey milling machine (Thomas Wiley® Mini-Mill; ASTM
D-3182; India), after which the ground samples were stored in air-
tight plastic bottles with screw caps pending extraction.
2.2. Extraction of herbal samples
A 40 g portion of each of the pulverized dried samples of
A. montanus, A. gangetica, E. coccinea, and H. rosasinensis were
subjected to repeated Soxhlet extraction cycles for 2 hours using
96% C2H5OH (BDH, UK) as solvent to obtain a ﬁnal volume of
500 mL of each herbal extract. These volumes of the herbal extracts
were concentrated and recovered in a rotary evaporator for 12
hours at 60 C under reduced pressure. The extracts were dried in a
desiccator for 24 hours, wrapped in aluminum foil, and stored in
air-tight plastic bottles with screw caps at  4 C. The yields were
calculated to be as follows: A. montanus ¼ 16.35% (w/w),A. gangetica ¼ 16.69% (w/w), E. coccinea ¼ 17.99% (w/w), and
H. rosasinensis ¼ 17.23% (w/w). The separate extracts were recon-
stituted in phosphate buffered saline (PBS) solution (extract
vehicle), osmotically equivalent to 100 g/L PBS (90.0 g NaCl, 17.0 g
Na2HPO4.2H2O, and 2.43 g NaH2PO4.2H2O), before appropriate
doses were administered to the experimental animals. Portions of
the individual herbal extracts were also measured for their
phytochemical contents.
2.3. Phytochemical composition of herbal extracts
Flavonoids content wasmeasured by themethods of Boham and
Kocipai.42 The concentration of alkaloids of the herbal extracts was
measured by the methods of Harborne.43 Measurement of saponin
content of the herbal extracts was performed according to the
methods of Harborne,43 as reported by Obadoni and Ochuko.44 The
Van-Burden and Robinson45 method as reported by Belonwu et al46
was used tomeasure concentration of tannins of the herbal extracts.
2.4. Experimental animals
Male albino (Wistar) rats (School of Agriculture and Agricultural
Technology (SAAT), Federal University of Technology, Owerri,
Nigeria) weighing between 150e160 g were maintained at room
temperatures of 24 ± 5 C, 30e55% of relative humidity on a 12-
hour light/12-hour dark cycle, with access to water and standard
commercial feed (SCF; Ewu Feed Mill, Edo State, Nigeria) ad libitum
for a 2-week acclimatization period. The handling of the animals
was in accordancewith the standard principles of laboratory animal
care of the United States National Institutes of Health (NIH, 1978).
2.5. Induction of diabetes/experimental design
Hyperglycemia was induced in the experimental rats by single
intraperitoneal (i.p.) injection of 90 mg/kg body weight of alloxan
monohydrate (Sigma-Aldrich, St. Louis, MO, USA) in PBS solution
(pH ¼ 7.4). The animals with fasting plasma glucose concentration
(FPGC) > 110 mg/dL for 5 consecutive days were considered hy-
perglycemic and selected for the study. A total of 102 male Wistar
rats were allotted into 17 groups of six rats each. The animals were
deprived of food and water for an additional 16 hours prior to the
commencement of treatment as described elsewhere.47 The animal
groups were designated on the basis of treatments received at
regular intervals of 2 days for 30 days. Herbal treatments of the
hyperglycemic rats (HyGR) were described as single herbal for-
mulations (SHf): (HrACMO, HrASGA, HrEMCO, and HrHIRO), double
herbal formulations (DHf): (HrAGAM, HrAGEC, HrAGHR, HrAMEC,
HrAMHR, and HrECHR), triple herbal formulations (THf): (HrAGEH,
HrAMAE, HrAMAH, and HrAMEH), and quadruple herbal formula-
tion (QHf): (HrAAEH).
 NORM: Normal rats received SCF þwater ad libitumþ 1.0 mL/kg
of PBS.
 DIAB: HyGR received SCF þwater ad libitumþ 1.0 mL/kg of PBS.
 HrACMO: HyGR received SCF þ water ad libitum þ A. montanus
(20 mg/kg in PBS; i.p.).
 HrASGA: HyGR received SCF þ water ad libitum þ A. gangetica
(20 mg/kg in PBS; i.p.).
 HrEMCO: HyGR received SCF þ water ad libitum þ E. coccinea
(20 mg/kg in PBS; i.p.).
 HrHIRO: HyGR received SCF þwater ad libitum þ H. rosasinensis
(20 mg/kg in PBS; i.p.)
 HrAGAM: HyGR received SCF þ water ad libitum þ combined
dose (ratio: 1:1 w/w) of A. gangetica þ A. montanus (20 mg/kg in
PBS; i.p.).
Table 1
Some phytochemical contents of Acanthus montanus, Asystasia gangetica, Emilia
coccinea, and Hibiscus rosasinensis herbal extracts.
Sample Concentrations of phytochemicals (mg/g dry sample)
Alkaloids Flavonoids Saponins Tannins
ACMO 177.25 ± 1.56b,c 561.00 ± 2.11a 71.00 ± 0.62a 26.5 ± 0.23a,b,c
ASGA 188.25 ± 1.02b 450.50 ± 1.98b 44.50 ± 0.51b,c 33.75 ± 0.32a
EMCO 352.75 ± 0.95a 345.00 ± 0.89d 43.50 ± 0.54b,c,d 29.50 ± 0.29a,b
HIRO 70.00 ± 0.67d 425.00 ± 1.71b,c 45.25 ± 0.35b 25.50 ± 0.18a,b,c,d
The mean (X) ± standard deviation of six (n ¼ 6) determinations. Means in the
column with the same letter are not signiﬁcantly different at p > 0.05.
ACMO ¼ Acanthus montanus; ASGA ¼ Asystasia gangetica; EMCO ¼ Emilia coccinea;
HIRO¼Hibiscus rosasinensis.
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dose (ratio: 1:1 w/w) of A. gangetica þ E. coccinea (20 mg/kg in
PBS; i.p.).
 HrAGHR: HyGR received SCF þ water ad libitum þ combined
dose (ratio: 1:1 w/w) of A. gangetica þ H. rosasinensis (20 mg/kg
in PBS; i.p.).
 HrAMEC: HyGR received SCF þ water ad libitum þ combined
dose (ratio: 1:1 w/w) of A. montanus þ E. coccinea (20 mg/kg in
PBS; i.p.).
 HrAMHR: HyGR received SCF þ water ad libitum þ combined
dose (ratio: 1:1 w/w) of A. montanus þ H. rosasinensis (20 mg/kg
in PBS; i.p.).
 HrECHR: HyGR received SCF þ water ad libitum þ combined
dose (ratio: 1:1w/w) of E. coccineaþH. rosasinensis (20 mg/kg in
PBS; i.p.).
 HrAGEH:HyGR received SCFþwaterad libitumþ combineddose
(ratio: 1:1:1 w/w) of A. gangetica þ E. coccinea þ H. rosasinensis
(20 mg/kg in PBS; i.p.).
 HrAMAE: HyGR received SCF þ water ad libitum þ combined
dose (ratio: 1:1:1w/w) ofA.montanusþA. gangeticaþ E. coccinea
(20 mg/kg in PBS; i.p.).
 HrAMAH:HyGRreceivedSCFþwaterad libitumþ combineddose
(ratio: 1:1:1w/w) of A. montanus þ A. gangeticaþ H. rosasinensis
(20 mg/kg in PBS; i.p.).
 HrAMEH:HyGRreceivedSCFþwaterad libitumþ combineddose
(ratio: 1:1:1 w/w) of A. montanus þ E. coccinea þ H. rosasinensis
(20 mg/kg in PBS; i.p.).
 HrAAEH: HyGR received SCF þ water ad libitum þ combined
dose (ratio: 1:1:1:1 w/w) of A. montanus þ A. gangetica þ
E. coccinea þ H. rosasinensis (20 mg/kg in PBS; i.p.).
Blood volumes of 2.0 mL were drawn from 12-hour post-fasted
animals on the 30th day experimental period and measured for
fasting plasma glucose concentration (FPGC) and serum lipid pro-
ﬁle (SLP).
2.6. Fasting plasma glucose concentration
Blood samples were drawn from the orbital sinus48 and
measured for FPGC. Estimation of FPGC was by the glucose oxidase
method according to Randox kit manufacturer's procedure (Randox
Laboratories Ltd, Ardmore, UK).
2.7. Serum lipid proﬁle
Blood samples were obtained from the various experimental
animal groups and measured for SLP according to the methods
previously described.49 Total cholesterol (TC), triacylglycerol (TAG),
and high-density lipoprotein cholesterol (HDL-C) were measured
using commercial kits (Randox Laboratory Ltd, Crumlin, Co. Antrim,
UK). Low-density lipoprotein cholesterol (LDL-C) concentration
was estimated according to the formula of Friedewald et al50;
LDL-C ¼ TC e (HDL-C) e (TAG/5), (1)




The results were expressed as mean ± standard error of the
mean, and statistically analyzed by one-way analysis of variancefollowed by the Dunnett test, with the level of signiﬁcance set at
p < 0.05.3. Results
Table 1 shows that ﬂavonoids were, in comparison, the most
abundant phytochemical present in the four herbal extracts, which
was in the following order: AMCO > ASGA > HIRO > EMCO;
p < 0.05. The concentration of alkaloids in HIRO was relatively low
comparedwith the other three herbal extracts, whereas EMCO gave
the highest concentration of alkaloids. Saponins contents of the
four herbal extracts were in the range of 43.50 ± 0.54 mg/g and
71.01 ± 0.62 mg/g. In addition, saponins contents amongst ASGA,
EMCO, and HIRO herbal extracts were not signiﬁcantly different
(p > 0.05) but signiﬁcantly (p < 0.05) lower than saponins content
of ACMO. Speciﬁcally, saponins contents were as follows:
ASGA ¼ 44.50 ± 0.51 mg/g, EMCO ¼ 43.50 ± 0.54 mg/g, and
HIRO ¼ 45.25 ± 0.35 mg/g (Table 1). Likewise, tannin contents of
the four herbal extracts was within a narrow range of
25.50 ± 0.18 mg/g and 33.75 ± 0.32 mg/g; p > 0.05. In addition,
among the four phytochemicals measured, tannin was the lowest
phytochemical present in the four herbal extracts.
The results presented in Fig. 1 show that FPGC of untreated
HyGR (DIAB group) was 4.26-fold higher than that of the control/
normal rats (NORM group). HyGR treated with SHf exhibited rela-
tively lower FPGC compared with the DIAB group. However,
HrACMO, HrEMCO, and HrHIRO showed evidence of hyperglycemia
(FPGC > 110 mg/dL) except HrASGA[FPGC] ¼ 105.7 ± 0.71 mg/dL.
Similarly, HyGR treated with DHf showed evidence of relatively
reduced FPGC compared with the DIAB group and were normo-
glycemic (FPGC < 110.0 mg/dL); except HrAGHR[FPGC] ¼
112.5 ± 0.42 mg/dL. Speciﬁcally, HrAGEC[FPGC] ¼ 81.0 ± 0.39 mg/dL
and HrAGAM[FPGC] ¼ 66.3 ± 0.71 mg/dL were normoglycemic
comparedwith NORM[FPGC]¼ 86.3± 0.51mg/dL. HyGR treatedwith
THf: HrAMAE[FPGC] ¼ 84.7 ± 0.51 mg/dL was normoglycemic,
whereas HrAMAH[FPGC] ¼ 124.3 ± 0.92 mg/dL indicated persistent
hyperglycemia after the 30-day treatment.
Serum total cholesterol (TC) of the DIAB group was not signiﬁ-
cantly different (p > 0.05) from that of the NORM group (Fig. 2).
HyGR treated with SHf; HrACMO[TC] ¼ 44.17 ± 2.31 mg/dL and
HrASGA[TC] ¼ 45.0 ± 2.92 mg/mL, exhibited reduced serum TC
that were signiﬁcantly (p < 0.05) lower than that of the NORM
group. However, HrEMCO[TC] ¼ 61.2 ± 2.13 mg/dL and
HrHIRO[TC] ¼ 58.0 ± 2.43 mg/dL were comparable with serum TC of
the NORM group; p > 0.05. Serum TC of HyGR treated with DHf was
within the range of 34.7 ± 2.34 mg/dL e 55.8 ± 1.53 mg/dL. Serum
TC of HrAGAM, HrAGEC, HrAGHR, HrAMEC, and HrAMHR showed
no signiﬁcant difference (p > 0.05) and were lower than the MORM
group. HrECHR[TC] ¼ 55.8 ± 1.53 mg/dL was not signiﬁcantly
different (p > 0.05) from serum TC of HyGR treated with SHf. Serum
Fig. 1. Fasting plasma glucose concentrations of normal, diabetic, and treated rats. ACMO ¼ Acanthus montanus; ASGA ¼ Asystasia gangetica; DHf ¼ double herbal formula;
EMCO ¼ Emilia coccinea; HIRO¼Hibiscus rosasinensis; NORM ¼ normal; SHf ¼ single herbal formula; THf ¼ triple herbal formula. AGAM ¼ combined dose (ratio: 1:1 w/w) of A.
gangetica + A. montanus; AGEC ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + E. coccinea; AGHR ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + H. rosasinensis; AMEC ¼
combined dose (ratio: 1:1 w/w) of A. montanus + E. coccinea; AMHR ¼ combined dose (ratio: 1:1 w/w) of A. montanus + H. rosasinensis; ECHR ¼ combined dose (ratio: 1:1 w/w) of E.
coccinea + H. rosasinensis; AGEH ¼ combined dose (ratio: 1:1:1 w/w) of A. gangetica + E. coccinea + H. rosasinensis; AMAE ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + A.
gangetica + E. coccinea; AMAH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + A. gangetica + H. rosasinensis; AMEH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + E.
coccinea + H. rosasinensis; AAEH ¼ combined dose (ratio: 1:1:1:1 w/w) of A. montanus + A. gangetica + E. coccinea + H. rosasinensis; FPGC ¼ fasting plasma glucose concentration.
Fig. 2. Serum total cholesterol concentrations of normal, diabetic, and treated rats. ACMO ¼ Acanthus montanus; ASGA ¼ Asystasia gangetica; DHf ¼ double herbal formula;
EMCO ¼ Emilia coccinea; HIRO¼Hibiscus rosasinensis; NORM ¼ normal; SHf ¼ single herbal formula; THf ¼ triple herbal formula. AGAM ¼ combined dose (ratio: 1:1 w/w) of A.
gangetica + A. montanus; AGEC ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + E. coccinea; AGHR ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + H. rosasinensis; AMEC ¼
combined dose (ratio: 1:1 w/w) of A. montanus + E. coccinea; AMHR ¼ combined dose (ratio: 1:1 w/w) of A. montanus + H. rosasinensis; ECHR ¼ combined dose (ratio: 1:1 w/w) of E.
coccinea + H. rosasinensis; AGEH ¼ combined dose (ratio: 1:1:1 w/w) of A. gangetica + E. coccinea + H. rosasinensis; AMAE ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + A.
gangetica + E. coccinea; AMAH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + A. gangetica + H. rosasinensis; AMEH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + E.
coccinea + H. rosasinensis; AAEH ¼ combined dose (ratio: 1:1:1:1 w/w) of A. montanus + A. gangetica + E. coccinea + H. rosasinensis; TC ¼ total cholesterol.
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that of the NORM group, whereas serum TC of HrAMAH, HrAMEH,
and HrAAEH were signiﬁcantly different (p < 0.05) from the DIAB
group.
Fig. 3 shows that DIAB[VLDL-C] ¼ 14.5 ± 2.13 mg/dL was not
signiﬁcantly different (p > 0.05) from the NORM[VLDL-
C] ¼ 12.9 ± 3.41 mg/dL. Serum very low density lipoprotein-choles-
terol (VLDL-C) of HyGR treated with SHf was within the range of
8.3 ± 2.14 mg/dL  14.0 ± 2.42 mg/dL that was not signiﬁcantly
different (p > 0.05) from that of the NORM and DIAB groups. The
HrAGHR[VLDL-C] ¼ 10.5 ± 0.84 mg/dL and HrAMEC[VLDL-
C]¼ 11.0± 1.61mg/dLwere signiﬁcantly lower than that of DIAB and
NORM groups. Conversely, the HrAMHR[VLDL-C] ¼ 17.0 ± 2.15 mg/dLwas signiﬁcantly (p < 0.05) higher than the DIAB[VLDL-C] ¼ 14.5
± 2.13 mg/dL.
The VLDL-C of HyGR treated with THf and QHf was within the
range of 10.8 ± 1.42 mg/dL e 14.5 ± 2.61 mg/dL, which was not
signiﬁcant different (p > 0.05) from that of the DIAB and NORM
groups.
Fig. 4 shows that DIAB[LDL-C] ¼ 27.9 ± 1.73 mg/dL was signiﬁ-
cantly higher than the NORM[LDL-C] ¼ 11.5 ± 1.22 mg/dL, which
represented an elevation of serum LDL-C by 2.4 folds. HyGR treated
with SHf exhibited signiﬁcant (p < 0.05) reduction in serum LDL-C
concentration when compared with that of the DIAB group, except
HrACMO[LDL-C] ¼ 9.7 ± 1.93 mg/dL < NORM[LDL-C] ¼ 11.5 ± 1.22 mg/
dL; p > 0.05.
Fig. 3. Serum very low density lipoprotein-cholesterol concentrations of normal, diabetic, and treated rats. ACMO ¼ Acanthus montanus; ASGA ¼ Asystasia gangetica; DHf ¼ double
herbal formula; EMCO ¼ Emilia coccinea; HIRO¼Hibiscus rosasinensis; NORM ¼ normal; SHf ¼ single herbal formula; THf ¼ triple herbal formula. AGAM ¼ combined dose (ratio:
1:1 w/w) of A. gangetica + A. montanus; AGEC ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + E. coccinea; AGHR ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + H. rosasinensis;
AMEC ¼ combined dose (ratio: 1:1 w/w) of A. montanus + E. coccinea; AMHR ¼ combined dose (ratio: 1:1 w/w) of A. montanus + H. rosasinensis; ECHR ¼ combined dose (ratio: 1:1 w/
w) of E. coccinea + H. rosasinensis; AGEH ¼ combined dose (ratio: 1:1:1 w/w) of A. gangetica + E. coccinea + H. rosasinensis; AMAE ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus +
A. gangetica + E. coccinea; AMAH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + A. gangetica + H. rosasinensis; AMEH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + E.
coccinea + H. rosasinensis; AAEH ¼ combined dose (ratio: 1:1:1:1 w/w) of A. montanus + A. gangetica + E. coccinea + H. rosasinensis; VLDL-C ¼ very low density lipoprotein-cholesterol.
Fig. 4. Serum low density lipoprotein-cholesterol concentrations of normal, diabetic, and treated rats. ACMO ¼ Acanthus montanus; ASGA ¼ Asystasia gangetica; DHf ¼ double
herbal formula; EMCO ¼ Emilia coccinea; HIRO¼Hibiscus rosasinensis; NORM ¼ normal; SHf ¼ single herbal formula; THf ¼ triple herbal formula. AGAM ¼ combined dose (ratio:
1:1 w/w) of A. gangetica + A. montanus; AGEC ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + E. coccinea; AGHR ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + H. rosasinensis;
AMEC ¼ combined dose (ratio: 1:1 w/w) of A. montanus + E. coccinea; AMHR ¼ combined dose (ratio: 1:1 w/w) of A. montanus + H. rosasinensis; ECHR ¼ combined dose (ratio: 1:1 w/
w) of E. coccinea + H. rosasinensis; AGEH ¼ combined dose (ratio: 1:1:1 w/w) of A. gangetica + E. coccinea + H. rosasinensis; AMAE ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus +
A. gangetica + E. coccinea; AMAH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + A. gangetica + H. rosasinensis; AMEH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + E.
coccinea + H. rosasinensis; AAEH ¼ combined dose (ratio: 1:1:1:1 w/w) of A. montanus + A. gangetica + E. coccinea + H. rosasinensis; LDL-C ¼ low density lipoprotein-cholesterol.
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centration when compared with that of the DIAB group. Further-
more, serum LDL-C of HyGR treated with DHf was within relatively
narrow range of 12.2 ± 3.72 mg/dL e 19.6 ± 2.12 mg/dL. HyGR
treated with THf: HrAMAH[LDL-C] ¼ 26.9 ± 1.31 mg/dL and HrA-
MEH[LDL-C] ¼ 24.4 ± 3.20 mg/dL were comparable with DIAB[LDL-
C] ¼ 27.9 ± 1.76 mg/dL; p > 0.05. Conversely, HrAAEH[LDL-
C] ¼ 18.8 ± 3.71 mg/dL was lower than that of DIAB[LDL-
C] ¼ 27.9 ± 1.73 mg/dL; p < 0.05.
The result presented in Fig. 5 show that NORM[HDL-
C] ¼ 29.5 ± 2.25 mg/dL > DIAB[HDL] ¼ 12.1 ± 1.53 mg/dL; p < 0.05.
Serum HDL-C of HyGR treated with SHf was within a relatively
narrow range of 29.8 ± 1.23 mg/dL e 30.2 ± 2.12 mg/dL, which wasnot signiﬁcantly different from the NORM[HDL-C] ¼ 29.5 ± 2.25
mg/dL. Among the HyGR treated with DHf, HrAGAM[HDL-
C] ¼ 31.5 ± 2.75 mg/dL represented the peak value of serum HDL-C,
whereas HrECHR[HDL-C] ¼ 23.7 ± 2.01 mg/dL gave the lowest value.
Similarly, serum HDL-C of HyGR treated with THf was within a
relatively narrow range of 20.3 ± 2.31 mg/dL e 24.8 ± 3.22 mg/dL;
p > 0.05. HrAAEH[HDL-C] ¼ 44.3 ± 2.21 mg/dL represented 3.66-fold
higher than the DIAB[HDL-C] ¼ 12.1 ± 1.53 mg/dL; p < 0.05.
DIAB[TAG] ¼ 72.5 ± 2.81 mg/dL > NORM[TAG] ¼ 64.3 ± 3.15 mg/dL
represented an 11.3% increase in serum TAG of the DIAB group;
p> 0.05 (Fig. 6). SerumTAGofHyGR treatedwith SHf varied between
60.8± 3.5mg/dL and70.2±5.0mg/dL; p>0.05. Although serumTAG
ofHyGR treatedwithDHfwere lower than that of theDIABgroup, the
Fig. 6. Serum triacylglycerol concentrations of normal, diabetic, and treated rats. ACMO ¼ Acanthus montanus; ASGA ¼ Asystasia gangetica; DHf ¼ double herbal formula;
EMCO ¼ Emilia coccinea; HIRO¼Hibiscus rosasinensis; NORM ¼ normal; SHf ¼ single herbal formula; THf ¼ triple herbal formula. AGAM ¼ combined dose (ratio: 1:1 w/w) of A.
gangetica + A. montanus; AGEC ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + E. coccinea; AGHR ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + H. rosasinensis; AMEC ¼
combined dose (ratio: 1:1 w/w) of A. montanus + E. coccinea; AMHR ¼ combined dose (ratio: 1:1 w/w) of A. montanus + H. rosasinensis; ECHR ¼ combined dose (ratio: 1:1 w/w) of E.
coccinea + H. rosasinensis; AGEH ¼ combined dose (ratio: 1:1:1 w/w) of A. gangetica + E. coccinea + H. rosasinensis; AMAE ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + A.
gangetica + E. coccinea; AMAH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + A. gangetica + H. rosasinensis; AMEH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + E.
coccinea + H. rosasinensis; AAEH ¼ combined dose (ratio: 1:1:1:1 w/w) of A. montanus + A. gangetica + E. coccinea + H. rosasinensis; TAG ¼ triacylglycerol.
Fig. 5. Serum high-density lipoprotein-cholesterol concentrations of normal, diabetic, and treated rats. ACMO ¼ Acanthus montanus; ASGA ¼ Asystasia gangetica; DHf ¼ double
herbal formula; EMCO ¼ Emilia coccinea; HIRO¼Hibiscus rosasinensis; NORM ¼ normal; SHf ¼ single herbal formula; THf ¼ triple herbal formula. AGAM ¼ combined dose (ratio:
1:1 w/w) of A. gangetica + A. montanus; AGEC ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + E. coccinea; AGHR ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + H. rosasinensis;
AMEC ¼ combined dose (ratio: 1:1 w/w) of A. montanus + E. coccinea; AMHR ¼ combined dose (ratio: 1:1 w/w) of A. montanus + H. rosasinensis; ECHR ¼ combined dose (ratio: 1:1 w/
w) of E. coccinea + H. rosasinensis; AGEH ¼ combined dose (ratio: 1:1:1 w/w) of A. gangetica + E. coccinea + H. rosasinensis; AMAE ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus +
A. gangetica + E. coccinea; AMAH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + A. gangetica + H. rosasinensis; AMEH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + E.
coccinea + H. rosasinensis; AAEH ¼ combined dose (ratio: 1:1:1:1 w/w) of A. montanus + A. gangetica + E. coccinea + H. rosasinensis; HDL-C ¼ high density lipoprotein-cholesterol.
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dL were profoundly lower than that of the NORM group; p < 0.05.
Likewise, HrAGEH[TAG] ¼ 54.3 ± 3.44 mg/dL was signiﬁcantly lower
than that of the NORM group. In addition, HrAMEH[TAG]
¼ 72.3 ± 2.34 mg/dL and HrAAEH[TAG] ¼ 71.0 ± 2.12 mg/dL were
not signiﬁcantly different (p > 0.05) from the DIAB[TAG]
¼ 72.5 ± 2.81 mg/dL.
Fig. 7 shows that HyGR treated with single and combinatorial
herbal formulations exhibited reduced AI compared with the DIAB
group; p < 0.05. In addition, AIs of HrAGAM, HrAGEC, HrAGHR,
HrAMEC, HrAMHR, and HrAAEHwere lower than that of the NORM
group. For instance,HrAGHRAI¼0.26±0.22<NORMAI¼0.93±0.19.Generally, HyGR treated with THfs exhibited the highest AIs
compared with other HyGR treated with SHfs, DHfs, and QHf.
4. Discussion
Phytochemicals are bioactive principles that have been widely
implicated in ameliorating vast array of clinical disorders and dis-
eases5,9 whose pathogenesis are remotely or directly connected
with oxidative stress.8,18,53 Bioactive principles of diverse plant
origins have been experimentally described to exhibit glycemic
control through varieties of mechanisms such as modulating the
activity or gene expression of enzymes related to antioxidant,
Fig. 7. Atherogenic indices of normal, diabetic, and treated rats. ACMO ¼ Acanthus montanus; ASGA ¼ Asystasia gangetica; DHf ¼ double herbal formula; EMCO ¼ Emilia coccinea;
NORM ¼ normal; SHf ¼ single herbal formula; THf ¼ triple herbal formula. AI ¼ AGAM ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + A. montanus; AGEC ¼ combined dose
(ratio: 1:1 w/w) of A. gangetica + E. coccinea; AGHR ¼ combined dose (ratio: 1:1 w/w) of A. gangetica + H. rosasinensis; AMEC ¼ combined dose (ratio: 1:1 w/w) of A. montanus + E.
coccinea; AMHR ¼ combined dose (ratio: 1:1 w/w) of A. montanus + H. rosasinensis; ECHR ¼ combined dose (ratio: 1:1 w/w) of E. coccinea + H. rosasinensis; AGEH ¼ combined dose
(ratio: 1:1:1 w/w) of A. gangetica + E. coccinea + H. rosasinensis; AMAE ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + A. gangetica + E. coccinea; AMAH ¼ combined dose (ratio:
1:1:1 w/w) of A. montanus + A. gangetica + H. rosasinensis; AMEH ¼ combined dose (ratio: 1:1:1 w/w) of A. montanus + E. coccinea + H. rosasinensis; AAEH ¼ combined dose (ratio:
1:1:1:1 w/w) of A. montanus + A. gangetica + E. coccinea + H. rosasinensis; AI ¼ atherogenic index.
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mimicry,8,24,55,56 improvement of hepatic glutathione concentra-
tion,8,57 inhibition of intestinal a-glucosidase, pancreatic lipase, and
cholesterol esterase activities,58 facilitated muscle uptake of
glucose,59,60 regeneration/proliferation of b-cells,24,61e64 and pro-
moting insulin and adrenaline secretions and antioxidative capa-
bility.8,65,66 Similarly, disarrangement in serum lipid proﬁle
engendered by lipemia in experimental animals have been suc-
cessfully readjusted and brought to normalcy by the actions of
bioactive principles of plant origins as previously demonstrated
elsewhere.49,58
Earlier reviews9,26 showed that alkaloids from varieties of plant
species exhibited glycemic control. For instance, according to Jung
et al9 alkaloids extract from Syzygium malaccense L. (Myrtaceae)
and Penares schulzei inhibited a-glucosidase activity. Furthermore,
the alkaloids inhibited glycogen phosphorylase both in vitro and
in vivo and stimulated basal glucose uptake rate in rat adipocytes.
Vinca rosea L. (Apocynaceae), also known as Madagascar peri-
winkle, is widely cultivated in the tropics mainly for its alkaloids
content, which possesses anticancer activities67e69 and tradition-
ally used for control diabetes from reports close to a century ago.70
Fresh leaf juice of Catharanthus roseus has been reported to reduce
blood glucose in normal and alloxan diabetic rabbits.71 Similarly,
Singh et al72 demonstrated that leaves and twigs of C. roseus
possess hypoglycemic activity in streptozotocin (STZ) induced
diabetic rats. These reports corroborated the current suggestion
that alkaloids in the herbal formulations served as an agent of
glycemic control.
According to Najaﬁan et al,73 ﬂavonoids are a-amylase inhibitors
and the intermediary biosynthetic precursor, notably trans-
chalcone, exhibit glycemic control in STZ-induced rat model of
type I DM. They further noted that the hypoglycemic effect of ﬂa-
vonoids and, by extension, its derivatives ameliorated dyslipidemia
in the diabetic rats. Zhou et al74 had previously corroborated these
reports in their investigations using ﬂavonoids from lotus (Nelumbo
nuﬁcera Gaertn) leaf administered to diabetic mice. The anti-
hyperlipidemic property of ﬂavonoids has equally been conﬁrmed
in cancer engendered dyslipidemia.75 In addition to these studies,Ma et al76 proposed the possible mechanism by which ﬂavonoids
display these therapeutic properties. They noted that the capability
of ﬂavonoids from Morus indica to normalize blood lipids and
glucose concentrations of high fat diet/low dose STZ-induced
hyperlipidemic and hyperglycemic rats, were in connection with
the upregulation of hepatic superoxide dismutase activity, reduc-
tion of hepatic malondialdehyde content, downregulation of he-
patic CYP2E1 expression, and increase of glucose transporter 4
(GLUT-4) expression in skeletal muscle of the treated rats. Addi-
tionally, previous clinical studies proposed the application of citrus
polymethoxylated ﬂavones (PMFs) as agents of glycemic control
and attenuation of insulin resistance,77e79 which was subsequently
demonstrated to be efﬁcacious against metabolic syndrome and
hyperlipidemia.9,80,81 Similar studies by Jung et al9 revealed that
ﬂavonoids caused increased adipocyte GLUT-4 activity, but
decreased GLUT-2 expression, and increased hepatic/adipocyte
peroxisome proliferator-activated receptor gamma (PPARg)
expression in treated animal models. Furthermore, ﬂavonoids eli-
cited decreased plasma and hepatic cholesterol levels through
suppression of hepatic 3-hydroxy-3-methylglutaryl-coenzyme A
(HMG-CoA) reductase and acyl CoA: cholesterol acyltransferase
(ACAT) activities with increased fecal cholesterol.9 Findings of the
present study showed that leaf extracts used for the various
experimental herbal formulations were relatively rich in ﬂavonoids
(Table 1), which obviously contributed to the observed glycemic
control and antihyperlipidemic capabilities of the herbal formula-
tions in the diabetic rats.
Similarly, saponins from Solanum anguivi fruit exhibited hypo-
glycemic, hypolipidemic, and antioxidant properties in alloxan-
induced diabetic rats,82 in which the therapeutic actions of sapo-
nins were described in the reports of Bhavsar et al.83 Accordingly,
they adduced that the bioactivity of saponins from Helicteres isora
was related to increased gene expression of adipsin, GLUT-4, and
PPARg and reduced gene expression of glucose-6-phosphatase
(G6Pase) and fatty acid binding protein 4 (FABP4) in treated dia-
betic mice. Also, steroidal saponin isolated from Momordica char-
antia L. was previously reported to possessing insulin-like activity.84
The beneﬁcial effect of saponins on hypercholesterolemia and
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been discussed elsewhere.40
The polyphenolic proanthocyanidin, commonly referred to as
condensed tannin, has been reported to exhibit antioxidant activ-
ity85,86 with antidiabetic property.87 According to Yokozawa et al,87
proanthocyanidin protected STZ-diabetic rats against hyperglyce-
mia and related disorders as well as hyperlipidemia through
modulation of general metabolism. In a related study, Velayutham
et al88 reported that tannin from Ficus racemosa attenuated
oxidative stress and ameliorated hyperglycemia and dyslipidemia
in diabetic rats. These previous ﬁndings, which corroborate the
outcomes of the current study, were obvious indications that the
therapeutic actions of alkaloids, ﬂavonoids, saponins, and tannins
were additive in the context of their collective capacities of these
phytochemicals to exert glycemic control and antihyperlipidemic
capabilities.24,89
Therefore, ﬂuctuating capacities of the herbal combinations to
alleviate hyperglycemia and hyperlipidemia in the animal models
(Figs. 1e7) were outcomes of chemical interactions amongst the
constituent phytochemicals of the various herbal formulations,
which could either be synergistic or antagonistic as previously
described.90e95 The display of synergy or antagonism by the com-
posite herbal extracts in ameliorating hyperglycemia and dyslipi-
demia depended on the type and number of individual herbal
extract used in constituting the experimental herbal formulations.
By implication, combination of the herbal extracts caused read-
justments in the absolute concentrations of the bioactive princi-
ples, and by extension affected the nature and outcome of their
interactions, which invariably dictated the therapeutic potentials of
the various herbal formulations.
5. Conclusion
An overview of the current results (Figs. 1e6) showed that the
capacities of the herbal formulations (SHfs, DHfs, THfs, and QHf) to
exert glycemic control and reverse dyslipidemia did not follow
predictable patterns in the animal models. However, the athero-
genic indices of the treated HyGR were signiﬁcantly (p < 0.05)
lower than that of the untreated diabetic rats and comparable with
the normal rats (Fig. 7).
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